TopLevel: No

VanDeMark separation is complete

28th September 2026

Submitted by:

Andrew Warmington

Japan’s Hodogaya Chemical has completed the previously announced acquisition of Hungarian API and intermediates producer

PharmaBlock opens OPC R&D centre

28th September 2026

Submitted by:

Andrew Warmington

China’s PharmaBlock has officially inaugurated its new Oligonucleotide, Peptide and Conjugates (OPC) R&D centre in

Curia to scale NCT process

28th September 2026

Submitted by:

Andrew Warmington

ExoZymes, which develops AI-enhanced enzymes that transform abundant feedstock into nutraceuticals and novel medicines, will

First peptide module opens

28th September 2026

Submitted by:

Andrew Warmington

The first of four scheduled modules has begun operations at Neuland Laboratories’ commercial-scale peptide manufacturing site

Subscribe to Most Read